Objective To explore the clinical effect of treating the ischemia of vertebral-basilar arteries by venous infusion of Yinxingdamo.Methods 116 cases of the patients suffering from the ischemia of vertebral-basilar arteries were divided randomly into two groups.In study group,66 patients were infused 20ml of Yinxingdamo injection added in 0.9% NS 250ml by I.V. q.d. for two weeks.In controlled group 50 patients were infused 20ml of compound danshen injection in 250ml 0.9% NS by I.V q.d. for two weeks.Results In study group,the symptoms of 55 cases were completely remissive,6 cases significantly improved,4 cases mildly improved,and no improvement was found in one case.In controlled group,the symptoms of 5 cases were completely remissive,18 cases significantly improved,16 cases mildly improved,and no improvement was found in 11 cases.In study group the total efficacy rate of 98.48% was significantly higher than that of controlled group which was 78%(P

Objective To discuss the curative effect and safety issues of Telsartan(Micardis) and Valsartan (Diovan) Capsule in curing light and to moderate essential hypertension patients. Methods The 126 light or moderate essential hypertension patients were divided into two groups randonly:63 patients in Micardis group(80mg qd)and 63 patients in Diovan group(160mg qd). The courses of treatment of each group were 8 weeks. The medicine was taken by patients after breakfast everyday. Data of blood pressure, heart rhythm, blood and urine routine test, hepatic and renal function, blood biochemistry test, ECG and side effects was recorded everyday before and after the treatment. Results After 8 weeks treatment, the average SBP of blood pressure was reduced from ( 156.3 ± 13.3 ) mm Hg to(128.6 ± 10.9) mm Hg(Micardis group)and (129.3 ± 11.3) mm Hg(Diovan group). The average DBP was reduced from(98.3±11.6) mm Hg to(80.3±7.1) mm Hg(Micardis group)and(80.6 ±7.3) mm Hg(Diovan group). The blood pressure of both group had notable decreasing after taking medicine(P ＜ 0.01). The total effective rates were 79.36% and 73.02%. In the same term,the curative effect of both group have significant difference(P＜0.05). In Micardis group,total Cholesterol(TC) level reduced from(5.6 ± 1.2) mmol/L to( 4.9 ± 1.1 ) mmol/L; Triglyceride (TG) level reduced from (2.38 ± 0.31) mmol/L to (2.23 ± 0.33) mmoL/L; Low Density Lipoprotein Cholesterol(LDL-C) level reduced from( 3.26 ± 0.38 ) mmol/L to( 2.89 ± 0.46 ) mmol/L; High Density Lipoprotein Cholesterol (HDL-C) level increased from ( 1.3 ± 0.6 ) mmol/L to ( 1.5 ± 0.3 ) mmol/L. As comparison, in the Diovan group only the TC level reduced from (5.6 ± 1.2) mmol/L to(5.2 ± 1.3) mmol/L. Both groups did not have significant adverse reactions. Conclusion As the Angiotensin Ⅱ Receptor Antagonist ( ARA), both the Telsartan and Valsartan Capsule were effective medicines in curing light and moderate essential hypertension patients. These two medicines which were reliable and safety,had good tolerance and few side effects. However,Telsartan had better effects than Diovan in reducing blood pressure and triglyceride on light or moderate essential hypertension patients. Also, Telsartan had longer half-life period(18-24h) and lower price.

A HPLC-ELSD method was developed and validated for simultaneous determination of five Hetisane-type diterpenoid alkaloids in a Tibetan traditional herbal medicine, “Gebu Dilu” (Herba Delphinii), using a Kromasil C18 column (250 mm ? 4.6 mm, 5μm) with the mobile phase consisting of acetonitrile and 0.1% triethylamine in gradient (detected by evaporative light scattering detector). The linear ranges of five compounds were determined and method validation was evaluated completely. The established method is rapid and accurate with high repeatability, and can be applied for the quality control of Herba Delphinii.